January 10, 2017 / 12:50 AM / 6 months ago

BRIEF-Immune Pharma to appeal for continued listing on the Nasdaq

1 Min Read

Jan 10 (Reuters) - Immune Pharmaceuticals Inc

* Immune Pharmaceuticals Inc - immune pharmaceuticals will request an appeal to regain compliance with nasdaq's minimum bid price rule Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below